Marketing-authorisation holder · United States
Sentiss
3 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CIPROFLOXACIN AND DEXAMETHASONE0.3%; 0.1% · Suspension/drops | Ciprofloxacin, Dexamethasone | United States | Marketed | 2020 |
| ERYTHROMYCIN0.5% | 5mg/gm · Ointment | Erythromycin | United States | Marketed | 1983 |
| KETOTIFEN FUMARATE0.025% base · Solution/drops | Ketotifen | United States | Marketed | 2006 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 3 | 3 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.